nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—saliva-secreting gland—thyroid cancer	0.0748	0.303	CbGeAlD
Icosapent ethyl—DGAT1—trachea—thyroid cancer	0.0577	0.234	CbGeAlD
Icosapent ethyl—DGAT1—thyroid gland—thyroid cancer	0.0456	0.185	CbGeAlD
Icosapent ethyl—DGAT1—head—thyroid cancer	0.0405	0.164	CbGeAlD
Icosapent ethyl—DGAT1—lymph node—thyroid cancer	0.0284	0.115	CbGeAlD
Icosapent ethyl—Icosapent—PPARG—thyroid cancer	0.0131	0.51	CrCbGaD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS2—thyroid cancer	0.00705	0.274	CrCbGaD
Icosapent ethyl—Rectal tenesmus—Doxorubicin—thyroid cancer	0.00608	0.00836	CcSEcCtD
Icosapent ethyl—Pancreatitis—Vandetanib—thyroid cancer	0.00604	0.0083	CcSEcCtD
Icosapent ethyl—Neoplasm—Sorafenib—thyroid cancer	0.00599	0.00823	CcSEcCtD
Icosapent ethyl—Bronchitis—Vandetanib—thyroid cancer	0.00592	0.00814	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Vandetanib—thyroid cancer	0.00555	0.00764	CcSEcCtD
Icosapent ethyl—Icosapent—PTGS2—thyroid cancer	0.00553	0.215	CrCbGaD
Icosapent ethyl—Pneumonia—Vandetanib—thyroid cancer	0.00552	0.00759	CcSEcCtD
Icosapent ethyl—Infestation NOS—Vandetanib—thyroid cancer	0.00549	0.00755	CcSEcCtD
Icosapent ethyl—Infestation—Vandetanib—thyroid cancer	0.00549	0.00755	CcSEcCtD
Icosapent ethyl—Eczema—Sorafenib—thyroid cancer	0.00535	0.00735	CcSEcCtD
Icosapent ethyl—Proctalgia—Epirubicin—thyroid cancer	0.00522	0.00717	CcSEcCtD
Icosapent ethyl—Epistaxis—Vandetanib—thyroid cancer	0.00518	0.00712	CcSEcCtD
Icosapent ethyl—Sinusitis—Vandetanib—thyroid cancer	0.00515	0.00708	CcSEcCtD
Icosapent ethyl—Peripheral vascular disorder—Epirubicin—thyroid cancer	0.00499	0.00686	CcSEcCtD
Icosapent ethyl—Proctalgia—Doxorubicin—thyroid cancer	0.00483	0.00664	CcSEcCtD
Icosapent ethyl—Peripheral vascular disorder—Doxorubicin—thyroid cancer	0.00462	0.00635	CcSEcCtD
Icosapent ethyl—Mood swings—Sorafenib—thyroid cancer	0.00455	0.00626	CcSEcCtD
Icosapent ethyl—Anorectal discomfort—Epirubicin—thyroid cancer	0.00448	0.00615	CcSEcCtD
Icosapent ethyl—Arrhythmia—Vandetanib—thyroid cancer	0.0044	0.00605	CcSEcCtD
Icosapent ethyl—Alopecia—Vandetanib—thyroid cancer	0.00436	0.00599	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00433	0.00595	CcSEcCtD
Icosapent ethyl—Malnutrition—Vandetanib—thyroid cancer	0.00429	0.0059	CcSEcCtD
Icosapent ethyl—Gastritis—Sorafenib—thyroid cancer	0.00425	0.00585	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.00424	0.00583	CcSEcCtD
Icosapent ethyl—Dysgeusia—Vandetanib—thyroid cancer	0.0042	0.00578	CcSEcCtD
Icosapent ethyl—Dysphagia—Sorafenib—thyroid cancer	0.00415	0.00571	CcSEcCtD
Icosapent ethyl—Anorectal discomfort—Doxorubicin—thyroid cancer	0.00414	0.00569	CcSEcCtD
Icosapent ethyl—Generalised oedema—Epirubicin—thyroid cancer	0.00411	0.00566	CcSEcCtD
Icosapent ethyl—Pancreatitis—Sorafenib—thyroid cancer	0.00407	0.0056	CcSEcCtD
Icosapent ethyl—Enlargement abdomen—Epirubicin—thyroid cancer	0.00407	0.00559	CcSEcCtD
Icosapent ethyl—Polyp—Epirubicin—thyroid cancer	0.00402	0.00553	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Sorafenib—thyroid cancer	0.00383	0.00526	CcSEcCtD
Icosapent ethyl—Generalised oedema—Doxorubicin—thyroid cancer	0.00381	0.00523	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Vandetanib—thyroid cancer	0.00377	0.00518	CcSEcCtD
Icosapent ethyl—Enlargement abdomen—Doxorubicin—thyroid cancer	0.00376	0.00517	CcSEcCtD
Icosapent ethyl—Cough—Vandetanib—thyroid cancer	0.00374	0.00515	CcSEcCtD
Icosapent ethyl—Pneumonia—Sorafenib—thyroid cancer	0.00373	0.00512	CcSEcCtD
Icosapent ethyl—Polyp—Doxorubicin—thyroid cancer	0.00372	0.00512	CcSEcCtD
Icosapent ethyl—Hypertension—Vandetanib—thyroid cancer	0.0037	0.00509	CcSEcCtD
Icosapent ethyl—Infestation NOS—Sorafenib—thyroid cancer	0.0037	0.00509	CcSEcCtD
Icosapent ethyl—Infestation—Sorafenib—thyroid cancer	0.0037	0.00509	CcSEcCtD
Icosapent ethyl—Cyst—Epirubicin—thyroid cancer	0.00366	0.00503	CcSEcCtD
Icosapent ethyl—Arthralgia—Vandetanib—thyroid cancer	0.00365	0.00502	CcSEcCtD
Icosapent ethyl—Chest pain—Vandetanib—thyroid cancer	0.00365	0.00502	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00365	0.00502	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Sorafenib—thyroid cancer	0.00363	0.00499	CcSEcCtD
Icosapent ethyl—Dry mouth—Vandetanib—thyroid cancer	0.00357	0.00491	CcSEcCtD
Icosapent ethyl—Oedema—Vandetanib—thyroid cancer	0.0035	0.00481	CcSEcCtD
Icosapent ethyl—Epistaxis—Sorafenib—thyroid cancer	0.00349	0.0048	CcSEcCtD
Icosapent ethyl—Infection—Vandetanib—thyroid cancer	0.00348	0.00478	CcSEcCtD
Icosapent ethyl—Hyperlipidaemia—Epirubicin—thyroid cancer	0.00339	0.00467	CcSEcCtD
Icosapent ethyl—Laryngitis—Epirubicin—thyroid cancer	0.00339	0.00467	CcSEcCtD
Icosapent ethyl—Cyst—Doxorubicin—thyroid cancer	0.00339	0.00466	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00319	0.00439	CcSEcCtD
Icosapent ethyl—Fungal infection—Epirubicin—thyroid cancer	0.00317	0.00436	CcSEcCtD
Icosapent ethyl—Insomnia—Vandetanib—thyroid cancer	0.00317	0.00435	CcSEcCtD
Icosapent ethyl—Hyperlipidaemia—Doxorubicin—thyroid cancer	0.00314	0.00432	CcSEcCtD
Icosapent ethyl—Laryngitis—Doxorubicin—thyroid cancer	0.00314	0.00432	CcSEcCtD
Icosapent ethyl—Dyspnoea—Vandetanib—thyroid cancer	0.00312	0.00429	CcSEcCtD
Icosapent ethyl—Dyspepsia—Vandetanib—thyroid cancer	0.00308	0.00424	CcSEcCtD
Icosapent ethyl—Decreased appetite—Vandetanib—thyroid cancer	0.00304	0.00419	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00302	0.00416	CcSEcCtD
Icosapent ethyl—Pain—Vandetanib—thyroid cancer	0.00299	0.00412	CcSEcCtD
Icosapent ethyl—Constipation—Vandetanib—thyroid cancer	0.00299	0.00412	CcSEcCtD
Icosapent ethyl—Arrhythmia—Sorafenib—thyroid cancer	0.00297	0.00408	CcSEcCtD
Icosapent ethyl—Alopecia—Sorafenib—thyroid cancer	0.00294	0.00404	CcSEcCtD
Icosapent ethyl—Fungal infection—Doxorubicin—thyroid cancer	0.00293	0.00403	CcSEcCtD
Icosapent ethyl—Malnutrition—Sorafenib—thyroid cancer	0.00289	0.00398	CcSEcCtD
Icosapent ethyl—Dysgeusia—Sorafenib—thyroid cancer	0.00283	0.0039	CcSEcCtD
Icosapent ethyl—Body temperature increased—Vandetanib—thyroid cancer	0.00277	0.00381	CcSEcCtD
Icosapent ethyl—Viral infection—Epirubicin—thyroid cancer	0.00271	0.00372	CcSEcCtD
Icosapent ethyl—Cough increased—Epirubicin—thyroid cancer	0.00267	0.00367	CcSEcCtD
Icosapent ethyl—Syncope—Sorafenib—thyroid cancer	0.0026	0.00357	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Sorafenib—thyroid cancer	0.00254	0.0035	CcSEcCtD
Icosapent ethyl—Cough—Sorafenib—thyroid cancer	0.00253	0.00347	CcSEcCtD
Icosapent ethyl—Asthenia—Vandetanib—thyroid cancer	0.00251	0.00345	CcSEcCtD
Icosapent ethyl—Viral infection—Doxorubicin—thyroid cancer	0.00251	0.00345	CcSEcCtD
Icosapent ethyl—Hypertension—Sorafenib—thyroid cancer	0.0025	0.00344	CcSEcCtD
Icosapent ethyl—Pruritus—Vandetanib—thyroid cancer	0.00248	0.00341	CcSEcCtD
Icosapent ethyl—Neck pain—Epirubicin—thyroid cancer	0.00248	0.00341	CcSEcCtD
Icosapent ethyl—Cough increased—Doxorubicin—thyroid cancer	0.00247	0.0034	CcSEcCtD
Icosapent ethyl—Arthralgia—Sorafenib—thyroid cancer	0.00246	0.00339	CcSEcCtD
Icosapent ethyl—Myalgia—Sorafenib—thyroid cancer	0.00246	0.00339	CcSEcCtD
Icosapent ethyl—Dry mouth—Sorafenib—thyroid cancer	0.00241	0.00331	CcSEcCtD
Icosapent ethyl—Eructation—Epirubicin—thyroid cancer	0.0024	0.00331	CcSEcCtD
Icosapent ethyl—Melaena—Epirubicin—thyroid cancer	0.00239	0.00329	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Sorafenib—thyroid cancer	0.00236	0.00325	CcSEcCtD
Icosapent ethyl—Colitis—Epirubicin—thyroid cancer	0.00235	0.00323	CcSEcCtD
Icosapent ethyl—Infection—Sorafenib—thyroid cancer	0.00235	0.00323	CcSEcCtD
Icosapent ethyl—Shock—Sorafenib—thyroid cancer	0.00232	0.0032	CcSEcCtD
Icosapent ethyl—Fluid retention—Epirubicin—thyroid cancer	0.00232	0.00319	CcSEcCtD
Icosapent ethyl—Dizziness—Vandetanib—thyroid cancer	0.00232	0.00318	CcSEcCtD
Icosapent ethyl—Neck pain—Doxorubicin—thyroid cancer	0.00229	0.00315	CcSEcCtD
Icosapent ethyl—Anorexia—Sorafenib—thyroid cancer	0.00225	0.0031	CcSEcCtD
Icosapent ethyl—Vomiting—Vandetanib—thyroid cancer	0.00223	0.00306	CcSEcCtD
Icosapent ethyl—Eructation—Doxorubicin—thyroid cancer	0.00222	0.00306	CcSEcCtD
Icosapent ethyl—Neoplasm—Epirubicin—thyroid cancer	0.00221	0.00304	CcSEcCtD
Icosapent ethyl—Melaena—Doxorubicin—thyroid cancer	0.00221	0.00304	CcSEcCtD
Icosapent ethyl—Rash—Vandetanib—thyroid cancer	0.00221	0.00304	CcSEcCtD
Icosapent ethyl—Dermatitis—Vandetanib—thyroid cancer	0.00221	0.00303	CcSEcCtD
Icosapent ethyl—Colitis—Doxorubicin—thyroid cancer	0.00217	0.00299	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00215	0.00296	CcSEcCtD
Icosapent ethyl—Fluid retention—Doxorubicin—thyroid cancer	0.00215	0.00296	CcSEcCtD
Icosapent ethyl—Dyspnoea—Sorafenib—thyroid cancer	0.00211	0.0029	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Epirubicin—thyroid cancer	0.00208	0.00286	CcSEcCtD
Icosapent ethyl—Dyspepsia—Sorafenib—thyroid cancer	0.00208	0.00286	CcSEcCtD
Icosapent ethyl—Decreased appetite—Sorafenib—thyroid cancer	0.00205	0.00282	CcSEcCtD
Icosapent ethyl—Neoplasm—Doxorubicin—thyroid cancer	0.00205	0.00281	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00204	0.0028	CcSEcCtD
Icosapent ethyl—Pain—Sorafenib—thyroid cancer	0.00202	0.00278	CcSEcCtD
Icosapent ethyl—Constipation—Sorafenib—thyroid cancer	0.00202	0.00278	CcSEcCtD
Icosapent ethyl—Eczema—Epirubicin—thyroid cancer	0.00198	0.00272	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00193	0.00265	CcSEcCtD
Icosapent ethyl—Increased appetite—Epirubicin—thyroid cancer	0.00189	0.0026	CcSEcCtD
Icosapent ethyl—Body temperature increased—Sorafenib—thyroid cancer	0.00187	0.00257	CcSEcCtD
Icosapent ethyl—Eczema—Doxorubicin—thyroid cancer	0.00183	0.00251	CcSEcCtD
Icosapent ethyl—Increased appetite—Doxorubicin—thyroid cancer	0.00175	0.00241	CcSEcCtD
Icosapent ethyl—Affect lability—Epirubicin—thyroid cancer	0.00175	0.0024	CcSEcCtD
Icosapent ethyl—Migraine—Epirubicin—thyroid cancer	0.00175	0.0024	CcSEcCtD
Icosapent ethyl—Asthenia—Sorafenib—thyroid cancer	0.00169	0.00233	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Epirubicin—thyroid cancer	0.00169	0.00232	CcSEcCtD
Icosapent ethyl—Mood swings—Epirubicin—thyroid cancer	0.00168	0.00231	CcSEcCtD
Icosapent ethyl—Pruritus—Sorafenib—thyroid cancer	0.00167	0.0023	CcSEcCtD
Icosapent ethyl—Migraine—Doxorubicin—thyroid cancer	0.00162	0.00222	CcSEcCtD
Icosapent ethyl—Affect lability—Doxorubicin—thyroid cancer	0.00162	0.00222	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.0016	0.0022	CcSEcCtD
Icosapent ethyl—Gastritis—Epirubicin—thyroid cancer	0.00157	0.00216	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00157	0.00215	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Doxorubicin—thyroid cancer	0.00156	0.00215	CcSEcCtD
Icosapent ethyl—Dizziness—Sorafenib—thyroid cancer	0.00156	0.00215	CcSEcCtD
Icosapent ethyl—Mood swings—Doxorubicin—thyroid cancer	0.00156	0.00214	CcSEcCtD
Icosapent ethyl—Abdominal distension—Epirubicin—thyroid cancer	0.00155	0.00212	CcSEcCtD
Icosapent ethyl—Asthma—Epirubicin—thyroid cancer	0.00154	0.00211	CcSEcCtD
Icosapent ethyl—Influenza—Epirubicin—thyroid cancer	0.00154	0.00211	CcSEcCtD
Icosapent ethyl—Dysphagia—Epirubicin—thyroid cancer	0.00154	0.00211	CcSEcCtD
Icosapent ethyl—Pancreatitis—Epirubicin—thyroid cancer	0.00151	0.00207	CcSEcCtD
Icosapent ethyl—Vomiting—Sorafenib—thyroid cancer	0.0015	0.00206	CcSEcCtD
Icosapent ethyl—Angina pectoris—Epirubicin—thyroid cancer	0.0015	0.00206	CcSEcCtD
Icosapent ethyl—Rash—Sorafenib—thyroid cancer	0.00149	0.00205	CcSEcCtD
Icosapent ethyl—Dermatitis—Sorafenib—thyroid cancer	0.00149	0.00205	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00148	0.00203	CcSEcCtD
Icosapent ethyl—Bronchitis—Epirubicin—thyroid cancer	0.00148	0.00203	CcSEcCtD
Icosapent ethyl—Gastritis—Doxorubicin—thyroid cancer	0.00145	0.002	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00145	0.00199	CcSEcCtD
Icosapent ethyl—Abdominal distension—Doxorubicin—thyroid cancer	0.00143	0.00197	CcSEcCtD
Icosapent ethyl—Dysphagia—Doxorubicin—thyroid cancer	0.00142	0.00195	CcSEcCtD
Icosapent ethyl—Influenza—Doxorubicin—thyroid cancer	0.00142	0.00195	CcSEcCtD
Icosapent ethyl—Asthma—Doxorubicin—thyroid cancer	0.00142	0.00195	CcSEcCtD
Icosapent ethyl—Pancreatitis—Doxorubicin—thyroid cancer	0.00139	0.00191	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Epirubicin—thyroid cancer	0.00138	0.0019	CcSEcCtD
Icosapent ethyl—Angina pectoris—Doxorubicin—thyroid cancer	0.00138	0.0019	CcSEcCtD
Icosapent ethyl—Pneumonia—Epirubicin—thyroid cancer	0.00138	0.00189	CcSEcCtD
Icosapent ethyl—Infestation NOS—Epirubicin—thyroid cancer	0.00137	0.00188	CcSEcCtD
Icosapent ethyl—Infestation—Epirubicin—thyroid cancer	0.00137	0.00188	CcSEcCtD
Icosapent ethyl—Bronchitis—Doxorubicin—thyroid cancer	0.00137	0.00188	CcSEcCtD
Icosapent ethyl—Sweating—Epirubicin—thyroid cancer	0.00131	0.0018	CcSEcCtD
Icosapent ethyl—Epistaxis—Epirubicin—thyroid cancer	0.00129	0.00178	CcSEcCtD
Icosapent ethyl—Sinusitis—Epirubicin—thyroid cancer	0.00128	0.00177	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00128	0.00176	CcSEcCtD
Icosapent ethyl—Pneumonia—Doxorubicin—thyroid cancer	0.00127	0.00175	CcSEcCtD
Icosapent ethyl—Infestation NOS—Doxorubicin—thyroid cancer	0.00127	0.00174	CcSEcCtD
Icosapent ethyl—Infestation—Doxorubicin—thyroid cancer	0.00127	0.00174	CcSEcCtD
Icosapent ethyl—Rhinitis—Epirubicin—thyroid cancer	0.00123	0.00169	CcSEcCtD
Icosapent ethyl—Pharyngitis—Epirubicin—thyroid cancer	0.00122	0.00168	CcSEcCtD
Icosapent ethyl—Sweating—Doxorubicin—thyroid cancer	0.00121	0.00167	CcSEcCtD
Icosapent ethyl—Epistaxis—Doxorubicin—thyroid cancer	0.00119	0.00164	CcSEcCtD
Icosapent ethyl—Sinusitis—Doxorubicin—thyroid cancer	0.00119	0.00163	CcSEcCtD
Icosapent ethyl—Rhinitis—Doxorubicin—thyroid cancer	0.00114	0.00157	CcSEcCtD
Icosapent ethyl—Pharyngitis—Doxorubicin—thyroid cancer	0.00113	0.00155	CcSEcCtD
Icosapent ethyl—Chills—Epirubicin—thyroid cancer	0.0011	0.00152	CcSEcCtD
Icosapent ethyl—Arrhythmia—Epirubicin—thyroid cancer	0.0011	0.00151	CcSEcCtD
Icosapent ethyl—Alopecia—Epirubicin—thyroid cancer	0.00109	0.00149	CcSEcCtD
Icosapent ethyl—Malnutrition—Epirubicin—thyroid cancer	0.00107	0.00147	CcSEcCtD
Icosapent ethyl—Dysgeusia—Epirubicin—thyroid cancer	0.00105	0.00144	CcSEcCtD
Icosapent ethyl—Back pain—Epirubicin—thyroid cancer	0.00103	0.00142	CcSEcCtD
Icosapent ethyl—Chills—Doxorubicin—thyroid cancer	0.00102	0.0014	CcSEcCtD
Icosapent ethyl—Arrhythmia—Doxorubicin—thyroid cancer	0.00102	0.0014	CcSEcCtD
Icosapent ethyl—Alopecia—Doxorubicin—thyroid cancer	0.001	0.00138	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Epirubicin—thyroid cancer	0.000992	0.00136	CcSEcCtD
Icosapent ethyl—Malnutrition—Doxorubicin—thyroid cancer	0.00099	0.00136	CcSEcCtD
Icosapent ethyl—Dysgeusia—Doxorubicin—thyroid cancer	0.000969	0.00133	CcSEcCtD
Icosapent ethyl—Malaise—Epirubicin—thyroid cancer	0.000965	0.00133	CcSEcCtD
Icosapent ethyl—Vertigo—Epirubicin—thyroid cancer	0.000961	0.00132	CcSEcCtD
Icosapent ethyl—Syncope—Epirubicin—thyroid cancer	0.000959	0.00132	CcSEcCtD
Icosapent ethyl—Back pain—Doxorubicin—thyroid cancer	0.000957	0.00132	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Epirubicin—thyroid cancer	0.00094	0.00129	CcSEcCtD
Icosapent ethyl—Cough—Epirubicin—thyroid cancer	0.000933	0.00128	CcSEcCtD
Icosapent ethyl—Hypertension—Epirubicin—thyroid cancer	0.000923	0.00127	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000918	0.00126	CcSEcCtD
Icosapent ethyl—Myalgia—Epirubicin—thyroid cancer	0.000911	0.00125	CcSEcCtD
Icosapent ethyl—Arthralgia—Epirubicin—thyroid cancer	0.000911	0.00125	CcSEcCtD
Icosapent ethyl—Chest pain—Epirubicin—thyroid cancer	0.000911	0.00125	CcSEcCtD
Icosapent ethyl—Discomfort—Epirubicin—thyroid cancer	0.0009	0.00124	CcSEcCtD
Icosapent ethyl—Malaise—Doxorubicin—thyroid cancer	0.000893	0.00123	CcSEcCtD
Icosapent ethyl—Dry mouth—Epirubicin—thyroid cancer	0.000891	0.00122	CcSEcCtD
Icosapent ethyl—Vertigo—Doxorubicin—thyroid cancer	0.000889	0.00122	CcSEcCtD
Icosapent ethyl—Syncope—Doxorubicin—thyroid cancer	0.000888	0.00122	CcSEcCtD
Icosapent ethyl—Oedema—Epirubicin—thyroid cancer	0.000873	0.0012	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Epirubicin—thyroid cancer	0.000873	0.0012	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Doxorubicin—thyroid cancer	0.00087	0.0012	CcSEcCtD
Icosapent ethyl—Infection—Epirubicin—thyroid cancer	0.000867	0.00119	CcSEcCtD
Icosapent ethyl—Cough—Doxorubicin—thyroid cancer	0.000864	0.00119	CcSEcCtD
Icosapent ethyl—Shock—Epirubicin—thyroid cancer	0.000859	0.00118	CcSEcCtD
Icosapent ethyl—Hypertension—Doxorubicin—thyroid cancer	0.000854	0.00117	CcSEcCtD
Icosapent ethyl—Tachycardia—Epirubicin—thyroid cancer	0.000852	0.00117	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Epirubicin—thyroid cancer	0.000844	0.00116	CcSEcCtD
Icosapent ethyl—Chest pain—Doxorubicin—thyroid cancer	0.000843	0.00116	CcSEcCtD
Icosapent ethyl—Myalgia—Doxorubicin—thyroid cancer	0.000843	0.00116	CcSEcCtD
Icosapent ethyl—Arthralgia—Doxorubicin—thyroid cancer	0.000843	0.00116	CcSEcCtD
Icosapent ethyl—Discomfort—Doxorubicin—thyroid cancer	0.000833	0.00114	CcSEcCtD
Icosapent ethyl—Anorexia—Epirubicin—thyroid cancer	0.000832	0.00114	CcSEcCtD
Icosapent ethyl—Dry mouth—Doxorubicin—thyroid cancer	0.000824	0.00113	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000808	0.00111	CcSEcCtD
Icosapent ethyl—Oedema—Doxorubicin—thyroid cancer	0.000808	0.00111	CcSEcCtD
Icosapent ethyl—Infection—Doxorubicin—thyroid cancer	0.000802	0.0011	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000795	0.00109	CcSEcCtD
Icosapent ethyl—Shock—Doxorubicin—thyroid cancer	0.000795	0.00109	CcSEcCtD
Icosapent ethyl—Insomnia—Epirubicin—thyroid cancer	0.00079	0.00109	CcSEcCtD
Icosapent ethyl—Tachycardia—Doxorubicin—thyroid cancer	0.000788	0.00108	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000781	0.00107	CcSEcCtD
Icosapent ethyl—Dyspnoea—Epirubicin—thyroid cancer	0.000778	0.00107	CcSEcCtD
Icosapent ethyl—Anorexia—Doxorubicin—thyroid cancer	0.00077	0.00106	CcSEcCtD
Icosapent ethyl—Dyspepsia—Epirubicin—thyroid cancer	0.000768	0.00106	CcSEcCtD
Icosapent ethyl—Decreased appetite—Epirubicin—thyroid cancer	0.000759	0.00104	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000754	0.00104	CcSEcCtD
Icosapent ethyl—Pain—Epirubicin—thyroid cancer	0.000747	0.00103	CcSEcCtD
Icosapent ethyl—Constipation—Epirubicin—thyroid cancer	0.000747	0.00103	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000736	0.00101	CcSEcCtD
Icosapent ethyl—Insomnia—Doxorubicin—thyroid cancer	0.000731	0.001	CcSEcCtD
Icosapent ethyl—Dyspnoea—Doxorubicin—thyroid cancer	0.00072	0.00099	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Epirubicin—thyroid cancer	0.000719	0.000989	CcSEcCtD
Icosapent ethyl—Dyspepsia—Doxorubicin—thyroid cancer	0.000711	0.000978	CcSEcCtD
Icosapent ethyl—Decreased appetite—Doxorubicin—thyroid cancer	0.000702	0.000965	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000697	0.000959	CcSEcCtD
Icosapent ethyl—Pain—Doxorubicin—thyroid cancer	0.000691	0.00095	CcSEcCtD
Icosapent ethyl—Constipation—Doxorubicin—thyroid cancer	0.000691	0.00095	CcSEcCtD
Icosapent ethyl—Body temperature increased—Epirubicin—thyroid cancer	0.00069	0.000949	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Doxorubicin—thyroid cancer	0.000666	0.000915	CcSEcCtD
Icosapent ethyl—Body temperature increased—Doxorubicin—thyroid cancer	0.000639	0.000878	CcSEcCtD
Icosapent ethyl—Asthenia—Epirubicin—thyroid cancer	0.000626	0.000861	CcSEcCtD
Icosapent ethyl—Pruritus—Epirubicin—thyroid cancer	0.000618	0.000849	CcSEcCtD
Icosapent ethyl—Asthenia—Doxorubicin—thyroid cancer	0.00058	0.000797	CcSEcCtD
Icosapent ethyl—Dizziness—Epirubicin—thyroid cancer	0.000577	0.000794	CcSEcCtD
Icosapent ethyl—Pruritus—Doxorubicin—thyroid cancer	0.000571	0.000786	CcSEcCtD
Icosapent ethyl—Vomiting—Epirubicin—thyroid cancer	0.000555	0.000763	CcSEcCtD
Icosapent ethyl—Rash—Epirubicin—thyroid cancer	0.00055	0.000757	CcSEcCtD
Icosapent ethyl—Dermatitis—Epirubicin—thyroid cancer	0.00055	0.000756	CcSEcCtD
Icosapent ethyl—Dizziness—Doxorubicin—thyroid cancer	0.000534	0.000734	CcSEcCtD
Icosapent ethyl—Vomiting—Doxorubicin—thyroid cancer	0.000514	0.000706	CcSEcCtD
Icosapent ethyl—Rash—Doxorubicin—thyroid cancer	0.000509	0.0007	CcSEcCtD
Icosapent ethyl—Dermatitis—Doxorubicin—thyroid cancer	0.000509	0.0007	CcSEcCtD
